PlainIndex

ETF comparison

AAXJ vs DGS

Both International Emerging.

iShares MSCI All Country Asia ex Japan ETF · WisdomTree Emerging Markets SmallCap Dividend Fund

Holdings overlap

0.0 %

0 positions appear in both funds. Buying equal dollars of AAXJ and DGS would leave roughly 0.0% of each dollar exposed to the same underlying securities.

AAXJ only 0.0% Shared 0.0% DGS only 0.0%
In AAXJ only
0 positions
Shared
0 positions
In DGS only
0 positions

Holdings data for AAXJ covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Holdings data for DGS covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Side by side

AAXJ

iShares MSCI All Country Asia ex Japan ETF

iShares · International Emerging

55 composite / 100
Expense ratio
0.72%
Net assets
$3.84B
TTM yield
1.54%
Top-10 conc.
—
DGS

WisdomTree Emerging Markets SmallCap Dividend Fund

WisdomTree · International Emerging

56 composite / 100
Expense ratio
0.58%
Net assets
$1.76B
TTM yield
3.31%
Top-10 conc.
—

Sub-score comparison

28
Cost
42
75
Tax efficiency
68
82
Liquidity
67
N/A
Concentration
N/A
—
Tracking quality
—
AAXJ sub-score DGS

Tracking-quality sub-score is not yet computed for any fund — see methodology for which inputs are live.

Cost difference

DGS is 14 bps cheaper than AAXJ. On a $100,000 position that's about $140/yr more in fees for AAXJ.

Fee figure is the annual expense charged on $100,000. It compounds over time — we publish a fuller cost-projection calculator on the methodology page.

Top shared holdings

0 shared in total

No shared holdings between these funds.

Only in AAXJ

0 total

Every AAXJ position is also held by DGS.

Only in DGS

0 total

Every DGS position is also held by AAXJ.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.